The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.

about

Individualised Multimodal Treatment Strategies for Anaplastic and Poorly Differentiated Thyroid Cancer.

P2860

Q54979096-9AFC556A-E7AA-4286-95C8-0E4E9C3FF664

P2860

The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.

Item

http://www.wikidata.org/entity/Q38865611

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.

@en

type

Item

label

The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.

@en

prefLabel

The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.

@en

P1476

The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.

@en

P2093

Francis P Worden

http://www.w3.org/2001/XMLSchema#string

Mark S Cohen

http://www.w3.org/2001/XMLSchema#string

Roy Lirov

http://www.w3.org/2001/XMLSchema#string

P2860

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer

Treatment of advanced thyroid cancer with targeted therapies: ten years of experience

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives

Contemporary Management of Recurrent Nodal Disease in Differentiated Thyroid Carcinoma

Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer

Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer

Extended Antitumor Response of a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial

P2888

s40265-017-0733-1

P304

733-745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-017-0733-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084038548

http://www.w3.org/2001/XMLSchema#string

P698

28361210

http://www.w3.org/2001/XMLSchema#string

P932

5683961

http://www.w3.org/2001/XMLSchema#string

The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.

about

P2860

P2860

The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932